Should I buy Nucor (NUE) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 64% of its targets hit on this sector (176 calls tested). It aims for $256 (+1.4 %), call made on July 29, 2026, maturing on July 29, 2027 (30 d ago).
Firm-by-firm track record on Nucor
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Goldman Sachs | 62 % | +42.8 % | 8 | $169 -33% |
| Keybanc | 55 % | +37.0 % | 11 | $274 +9% |
| UBS | 75 % | +25.4 % | 8 | $256 +1% |
| Morgan Stanley | 75 % | +21.1 % | 8 | $258 +2% |
| JP Morgan | 67 % | +21.1 % | 18 | $282 +12% |
| Jefferies | 73 % | +19.4 % | 11 | $190 -25% |
| B of A Securities | 50 % | +4.8 % | 6 | $280 +11% |
| Barclays | 60 % | +3.9 % | 5 | $295 +17% |
✅ Reasons to believe
- 78% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $280, i.e. +11% from the current price ($252).
- The most reliable firm on NUE, BMO Capital (100% hit rate, 2 scored calls), targets $295 (call made on July 29, 2026, maturing on July 29, 2027) (+17%) in its most recent call, and $235 (call made on April 28, 2026, maturing on April 28, 2027) (-7%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 9 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on NUE
Median target $280 (+11%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Nucor now?
We won't decide for you. The facts: 78% of analysts rate it a buy, median target $280 (+11%), and BMO Capital (most reliable on NUE, 100%) targets $295. Weigh that against valuation (P/E ~20). This is not personalized advice.
Is it too late to invest in Nucor?
Not according to analysts: the median target ($280) is still +11% above the current price ($252) (most reliable on NUE: BMO Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Nucor still worth investing in?
It depends on the gap between the price ($252) and its estimated value: analysts target $280 on median (+11%), with 78% buys (most reliable on NUE: BMO Capital, 100%). Cross-check with their real reliability on NUE and the cautions above. Information, not advice.
What's the main risk in buying NUE?
The consensus is not unanimous: of 9 ratings, 2 are neutral.
→ Go deeper: the full Nucor profile (consensus, analyst reliability, price target, performance).